GENE ONLINE|News &
Towards Exosome-Based Theranostics for Alzheimer’s Disease
With high biocompatibility combined with the ability to pass through BBB and carry drug payloads, exosomes have huge potential in treating AD.
Exosomes by themselves or as vehicles for drug delivery offer a Trojan horse strategy that could be exploited for treatments. In summary, the utilization of exosomes as novel theranostics offers hope in treating a devastating disease like AD.
Exosomes by themselves or as vehicles for drug delivery offer a Trojan horse strategy that could be exploited for treatments. In summary, the utilization of exosomes as novel theranostics offers hope in treating a devastating disease like AD.
GO Prime with only $1.49 now
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
2026-04-17
AACR Annual Meeting 2026 (Cancer Research & Early-Stage Breakthroughs)
San Diego, California
